A continually updated list of centrally authorised products (updated 2025-09-14)
Cancer medicines for children
Category: EMA
Regulatory science, Drug development tools (DDTs)
A list of tools such as biomarkers, simulation approaches, new endpoints, novel methods, commented by regulatory agencies, updated daily
Information on medicines and assessments
Interactive webapp about centrally authorised medicines and their assessments (EPARs), updated daily
PIPs – Paediatric medicines investigations
A searchable webapp showing details of development plans (PIPs), updated daily
Adult cancer medicines: starting trials with children
Many are relevant to be studied in children with cancer (updated 2022-04-24)Development going beyond rare adult tumour
Examples of medicines with development for children triggered by melanoma in adults (updated 2021-12-30)